Danaher Corporation (NYSE:DHR) stock has experienced a notable downturn, reaching a 52-week low of $225.36. With a market ...
The stock of Danaher (DHR) is down about 10% after the medical device maker reported mixed results for the fourth quarter of ...
Stifel analysts reduced the price target for Danaher Corporation shares (NYSE:DHR) to $260 from the previous target of $265, while maintaining a Hold rating on the stock. The new target sits within ...
Danaher (DHR) stock trades ~5% lower as the company, with its Q4 2024 results, projects a sales contraction in the current ...
TD Cowen analyst Dan Brennan lowered the firm’s price target on Danaher (DHR) to $260 from $315 and keeps a Buy rating on the shares. The firm ...
Danaher's Q4 earnings missed expectations due to a decline in its diagnostics segment, despite stronger sales in ...
Danaher Corporation DHR reported weaker-than-expected fourth-quarter earnings on Wednesday. The company reported fourth-quarter adjusted earnings per share of $2.14 missing the street view of $2.16.
U.S. stocks slipped after the Federal Reserve held its main interest rate steady and broke a run of cuts that began in ...